Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Express Scripts
Baxter
Merck
Dow

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Research Foundation of State University of New York v. Lupin Limited (D. Del. 2009)

See Plans and Pricing

« Back to Dashboard

Research Foundation of State University of New York v. Lupin Limited (D. Del. 2009)

Docket   Start Trial Date Filed 2009-07-02
Court District Court, D. Delaware Date Terminated 2012-02-06
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Defendant Referred To
Parties GALDERMA LABORATORIES INC.; GALDERMA LABORATORIES LP; LUPIN LIMITED; LUPIN PHARMACEUTICALS INC.; NEW YORK UNIVERSITY; RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Patents 5,789,395; 5,919,775; 7,211,267; 7,232,572
Attorneys Brian E. Farnan; Jack B. Blumenfeld; John C. Phillips , Jr.; Thomas Francis Driscoll , III
Firms Bifferato LLC; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Research Foundation of State University of New York v. Lupin Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Research Foundation of State University of New York v. Lupin Limited (D. Del. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-08-31 11 of U.S. Patent Nos. 7,232,572 (“the ‘572 patent”); 7,211,267 (“the ‘267 patent”); 5,789,395 (“the °395…and/or enforceable claim of U.S. Patent No. 5,789,395 (“the ‘395 patent”), either literally or under the…Office (“PTO”) issued U.S. Patent No. 5,789,395 (“the ‘395 patent”), entitled “Method of Using Tetracycline…267 patent, the ‘395 patent and the ‘775 patent are attached to the Complaint as Exhibits A-D, respectively…“the ‘775 patent”). Lupin further admits that what purports to be copies of the ‘572 patent, the ‘267 External link to document
2012-09-05 39 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,232,572; 7,211,267; 5,789,395; 5,919,775…2009 6 February 2012 1:09-cv-00483 830 Patent Defendant District Court, D. External link to document
2014-01-08 46 for Claims 2 and 14 of U.S. Patent No. 5,789,395 and Claim 2 of U.S. Patent No. 5,919,775 by Galderma Laboratories…2009 6 February 2012 1:09-cv-00483 830 Patent Defendant District Court, D. External link to document
2009-07-06 7 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,232,572 B2; 7,211,267 B2; 5,789,395; 5,919,775…2009 6 February 2012 1:09-cv-00483 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Colorcon
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.